Phase 3 biotech developing novel therapies for gastrointestinal diseases.
Industry: Health Care
First Day Return: +29.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/30/2019 |
Offer Price | $19.00 |
Price Range $18.00 - $20.00 | |
Offer Shares (mm) | 9.6 |
Deal Size ($mm) | $182 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/24/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $182 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Buffalo Grove, IL, United States |
Founded | 2018 |
Employees at IPO | 16 |
Website www.phathompharma.com |